Melanie Sena

A new report from PhRMA outlines potential growth trajectories affecting the biopharmaceutical industry.

FDA develops an assay that could speed the release of pandemic influenza vaccines.

Merck promotes internal managers to head Merck Millipore and Consumer Health Divisions.

Ben Venue issues a voluntary patient level recall of Acetylcysteine Solution 10% due to glass particle in vial.

Innovative Medicines Initiative will develop novel antibiotics against gram-negative pathogens in a project called ENABLE.

New medicines in development include treatments for type 1 and type 2 diabetes.

Mylan Pharmaceuticals launches Hertraz, the world's first trastuzumab biosimilar in India.

Shire appoints Susan Kilsby as its New Chairman.

Bind Therapeutics amends its development and commercialization collaboration agreement with Amgen.

Coldstream Laboratories names director of formulation development.